The Association of Gut Microbiota With COVID 19 Infection in Children
Sponsor
Hallym University Kangnam Sacred Heart Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05303155
Collaborator
(none)
40
21
Study Details
Study Description
Brief Summary
Although COVID-19 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. The investigators will analyze the alterations in fecal microbiomes of patients with COVID-19 infection during hospitalization.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
40 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Association of Gut Microbiota With Early Infection Stages of COVID-19 in Children
Anticipated Study Start Date
:
Apr 14, 2022
Anticipated Primary Completion Date
:
Jan 14, 2023
Anticipated Study Completion Date
:
Jan 14, 2024
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patient with COVID 19 Pediatric patient infected by COVID 19 |
Diagnostic Test: 16S rRNA sequencing
Fecal microbiome analysis using 16S rRNA sequencing
|
Pediatric patient without infection of COVID 19 Pediatric patient without infection of COVID 19 |
Diagnostic Test: 16S rRNA sequencing
Fecal microbiome analysis using 16S rRNA sequencing
|
Outcome Measures
Primary Outcome Measures
- The analysis of fecal microbiome of patient with COVID 19 [through study completion, an average of 1 year]
The analysis of fecal microbiome of patient with COVID 19, using 16S rRNA sequencing
Eligibility Criteria
Criteria
Ages Eligible for Study:
3 Months
to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- patients infected with COVID 19
Exclusion Criteria:
-
congenital heart, renal, intestinal disease
-
malignancy
-
immunologic disease
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Hallym University Kangnam Sacred Heart Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hallym University Kangnam Sacred Heart Hospital
ClinicalTrials.gov Identifier:
NCT05303155
Other Study ID Numbers:
- Covid 19 and Gut Microbiota
First Posted:
Mar 31, 2022
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: